ABT Abbott Laboratories

Price (delayed)

$103.08

Market cap

$180.52B

P/E Ratio

21.34

Dividend/share

$1.86

EPS

$4.83

Enterprise value

$188.34B

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights
ABT's P/E is 69% below its 5-year quarterly average of 69.9 and 25% below its last 4 quarters average of 28.6
The EPS has grown by 35% YoY and by 11% from the previous quarter

Key stats

What are the main financial stats of ABT
Market
Shares outstanding
1.75B
Market cap
$180.52B
Enterprise value
$188.34B
Valuations
Price to earnings (P/E)
21.34
Price to book (P/B)
4.92
Price to sales (P/S)
3.97
EV/EBIT
17.81
EV/EBITDA
13.5
EV/Sales
4.13
Earnings
Revenue
$45.55B
EBIT
$10.58B
EBITDA
$13.95B
Free cash flow
$8.47B
Per share
EPS
$4.83
Free cash flow per share
$4.83
Book value per share
$20.97
Revenue per share
$25.97
TBVPS
$22.73
Balance sheet
Total assets
$74.2B
Total liabilities
$37.49B
Debt
$16.76B
Equity
$36.72B
Working capital
$12.56B
Liquidity
Debt to equity
0.46
Current ratio
2.01
Quick ratio
1.33
Net debt/EBITDA
0.56
Margins
EBITDA margin
30.6%
Gross margin
58%
Net margin
18.8%
Operating margin
22.4%
Efficiency
Return on assets
11.5%
Return on equity
23.9%
Return on invested capital
30.6%
Return on capital employed
17.1%
Return on sales
23.2%
Dividend
Dividend yield
1.8%
DPS
$1.86
Payout ratio
38.5%

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
3.58%
1 week
4.83%
1 month
0.57%
1 year
-10.78%
YTD
-26.76%
QTD
6.53%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$45.55B
Gross profit
$26.44B
Operating income
$10.21B
Net income
$8.55B
Gross margin
58%
Net margin
18.8%
The operating income has grown by 37% YoY and by 11% from the previous quarter
Abbott Laboratories's net income has increased by 34% YoY and by 11% QoQ
Abbott Laboratories's operating margin has increased by 21% YoY and by 8% from the previous quarter
Abbott Laboratories's net margin has increased by 19% YoY and by 8% QoQ

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
P/E
21.34
P/B
4.92
P/S
3.97
EV/EBIT
17.81
EV/EBITDA
13.5
EV/Sales
4.13
ABT's P/E is 69% below its 5-year quarterly average of 69.9 and 25% below its last 4 quarters average of 28.6
The EPS has grown by 35% YoY and by 11% from the previous quarter
ABT's price to book (P/B) is 18% lower than its last 4 quarters average of 6.0
ABT's equity is up by 8% year-on-year and by 3.1% since the previous quarter
ABT's P/S is 19% below its last 4 quarters average of 4.9 and 16% below its 5-year quarterly average of 4.7
The revenue has grown by 13% YoY and by 2.3% from the previous quarter

Efficiency

How efficient is Abbott Laboratories business performance
The ROIC has grown by 33% YoY and by 9% from the previous quarter
Abbott Laboratories's return on assets has increased by 29% YoY and by 11% QoQ
ABT's ROE is up by 24% YoY and by 9% from the previous quarter
The ROS has grown by 20% YoY and by 8% from the previous quarter

Dividends

What is ABT's dividend history
DPS
$1.86
Dividend yield
1.8%
Payout ratio
38.5%
Recent dividends

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 98% more than the total liabilities
The current ratio has increased by 12% YoY and by 9% QoQ
ABT's quick ratio is up by 12% year-on-year and by 10% since the previous quarter
Abbott Laboratories's debt is 54% lower than its equity
Abbott Laboratories's debt to equity has decreased by 15% YoY and by 4.2% from the previous quarter
Abbott Laboratories's debt has decreased by 9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.